Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fuisz FlashDose ibuprofen, acetaminophen to be produced at newly acquired Clonmel plant.

This article was originally published in The Tan Sheet

Executive Summary

FUISZ FLASHDOSE ACETAMINOPHEN, IBUPROFEN WILL BE MANUFACTURED at the facilities of the pharmaceutical firm Clonmel Healthcare, based in Clonmel, Ireland, pending approval and closure of Fuisz' acquisition of the company. Chantilly, Va.-based Fuisz Technologies announced July 29 that it has signed definitive agreements with the Cross Group, Clonmel's parent company, for the acquisition. Fuisz previously announced an interest in European growth opportunities because of the region's "abbreviated timeframe" for product development ("The Tan Sheet" March 3, p. 14).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel